Merck | MRK - Net Income


Merck reported EUR659M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Adidas EUR 355M 127M Jun/2026
Adyen EUR 581.56M 100.6M Dec/2025
Akzo Nobel EUR 139M 46M Jun/2026
Alcon AG USD 189M 28M Mar/2026
Amadeus IT EUR 343.7M 13.3M Jun/2026
Amarin USD -1.22M 6.51M Dec/2025
AstraZeneca USD 2.51B 573M Jun/2026
BASF EUR 4.14B 3.22B Jun/2026
Bayer EUR 2.76B 6.52B Mar/2026
Beiersdorf EUR 387M 165M Dec/2025
Covestro EUR -378M 331M Dec/2025
Danone EUR 1.17B 388M Jun/2026
Fresenius EUR 382M 53M Jun/2026
Fresenius Medical Care EUR 118M 209M Mar/2026
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 435M 1.3B Jun/2026
GRIFOLS EUR 154M 81M Jun/2026
Henkel EUR 988M 63M Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Infineon EUR 419M 122M Jun/2026
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Linde USD 1.86B 327M Mar/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Novartis USD 3.26B 108M Jun/2026
Philips EUR 384M 233M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
UCB EUR 1.08B 608M Dec/2025